New Zealand Blood-based Biomaker For Sports Medicine Market Size & Outlook
New Zealand blood-based biomaker for sports medicine market, 2018-2030 (US$M)
Related Markets
New Zealand blood-based biomaker for sports medicine market highlights
- The New Zealand blood-based biomaker for sports medicine market generated a revenue of USD 9.0 million in 2023 and is expected to reach USD 16.4 million by 2030.
- The New Zealand market is expected to grow at a CAGR of 8.9% from 2024 to 2030.
- In terms of segment, ck was the largest revenue generating type in 2023.
- CRP is the most lucrative type segment registering the fastest growth during the forecast period.
Blood-based biomaker for sports medicine market data book summary
| Market revenue in 2023 | USD 9.0 million |
| Market revenue in 2030 | USD 16.4 million |
| Growth rate | 8.9% (CAGR from 2023 to 2030) |
| Largest segment | Ck |
| Fastest growing segment | CRP |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | CK, Myoglobin, Lactate, WBC, Urea, CRP, Lipid and Protein Hydroperoxides, IL-6 |
Other key industry trends
- In terms of revenue, New Zealand accounted for 1.4% of the global blood-based biomaker for sports medicine market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Asia Pacific, China blood-based biomaker for sports medicine market is projected to lead the regional market in terms of revenue in 2030.
- India is the fastest growing regional market in Asia Pacific and is projected to reach USD 25.9 million by 2030.
Ck was the largest segment with a revenue share of 17.78% in 2023. Horizon Databook has segmented the New Zealand blood-based biomaker for sports medicine market based on ck, myoglobin, lactate, wbc, urea, crp, lipid and protein hydroperoxides, il-6 covering the revenue growth of each sub-segment from 2018 to 2030.
In New Zealand, sports injuries, particularly in soccer & cricket, have prompted significant insurance claims and increased spending on injury management. According to a report by Austin Publishing Group, between 2010 and 2020, there were 429,681 injury entitlement claims, amounting to USD 420.59 million in costs.
This indicates a notable rise in injury claims over the decade, reflecting the growing need for effective injury management and prevention strategies. Moreover, this improved focus on blood-based diagnostics aligns with the rise in sports injury-related insurance claims and spending. Furthermore, the market is driven by the need for better prevention and management solutions, leading to more precise and effective treatment options for athletes.
Similarly, according to the BMJ Journal, in 2022, 86,562 injuries were reported over a 12-year period, with 77,212 affecting males and 9,350 affecting females. The injury rate was notably higher for males, at 64.1 per 1,000 participants, compared to 36.1 for females. Although cricket-related injury claims rose by 42.6%, the overall injury incidence in cricket decreased from 59.0 per 1,000 participants in 2006 to 42.8 in 2016.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Blood-based Biomaker for Sports Medicine Market Scope
Blood-based Biomaker for Sports Medicine Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
New Zealand blood-based biomaker for sports medicine market size, by type, 2018-2030 (US$M)
New Zealand Blood-based Biomaker for Sports Medicine Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
